| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.832 | 16.581 | - | 12.912 | 7.740 | 21.954 | 15.201 | 33.112 | 60.243 | 26.299 |
| Total Income - EUR | 12.832 | 16.581 | - | 12.912 | 7.748 | 21.998 | 15.222 | 33.228 | 60.777 | 26.704 |
| Total Expenses - EUR | 3.959 | 10.813 | - | 7.269 | 4.610 | 2.887 | 4.501 | 19.521 | 38.905 | 40.148 |
| Gross Profit/Loss - EUR | 8.873 | 5.769 | - | 5.643 | 3.138 | 19.111 | 10.720 | 13.707 | 21.872 | -13.444 |
| Net Profit/Loss - EUR | 8.488 | 5.271 | - | 5.255 | 2.905 | 18.450 | 10.264 | 13.157 | 21.241 | -13.721 |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Eurofarma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23.307 | 14.380 | - | 38.599 | 36.111 | 33.719 | 32.410 | 30.615 | 30.263 | 32.142 |
| Current Assets | 917 | 2.597 | - | 5.371 | 16.530 | 35.765 | 28.885 | 25.020 | 23.971 | 5.737 |
| Inventories | 0 | 0 | - | 514 | 504 | 494 | 483 | 0 | 0 | 0 |
| Receivables | 906 | 2.469 | - | 3.870 | 11.324 | 11.238 | 11.888 | 12.697 | 0 | 1.203 |
| Cash | 11 | 128 | - | 987 | 4.701 | 24.033 | 16.514 | 12.323 | 23.971 | 4.534 |
| Shareholders Funds | -12.976 | -6.950 | - | 19.097 | 27.955 | 45.988 | 50.849 | 39.996 | 48.457 | 34.465 |
| Social Capital | 832 | 824 | - | 795 | 6.048 | 5.933 | 5.802 | 5.820 | 5.802 | 5.770 |
| Debts | 37.200 | 23.926 | - | 24.872 | 24.686 | 23.496 | 10.446 | 15.639 | 5.777 | 3.415 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Eurofarma Srl